Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expression of cripto in human gall bladder lesions

K Fujii1, W Yasui, H Kuniyasu

  • 1First Department of Pathology, Hiroshima University School of Medicine, Japan.

The Journal of Pathology
|October 1, 1996
PubMed
Summary

Cripto expression, a growth factor, was found in most gallbladder lesions, including hyperplasias, adenomas, and adenocarcinomas. Its presence correlates with tumor differentiation, not progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coamplification of cyclin-d, hst-1 and int-2 genes is a good biological marker of high malignancy for human esophageal carcinomas.

Oncology reports·2011
Same author

Expression of e-cadherin, alpha-catenins and Beta-catenins in human gastric carcinomas - correlation with histology and tumor progression.

Oncology reports·2011
Same author

Increased expression and phosphorylation of sh-ptp2 (syp) in human gastric carcinomas.

Oncology reports·2011
Same author

A splice variant of the c-met proto-oncogene is the predominant population expressed in human gastric mucosa and carcinoma.

Oncology reports·2011
Same author

Genetic abnormalities and expression of p53 in human colon carcinomas.

International journal of oncology·2011
Same author

Biologic effect of human hepatocyte growth-factor on human gastric-carcinoma cell-lines.

International journal of oncology·2011

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Cripto is a member of the epidermal growth factor (EGF) family.
  • Understanding Cripto's role in gallbladder pathology is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate the expression of Cripto in benign and malignant gallbladder lesions.
  • To determine the correlation between Cripto expression and clinicopathological features of gallbladder carcinomas.

Main Methods:

  • Immunohistochemistry was used to detect Cripto expression.
  • Analysis included benign lesions (hyperplasias, adenomas) and gallbladder adenocarcinomas.
  • Expression levels were correlated with tumor invasion depth, stage, differentiation, and patient prognosis.

Related Experiment Videos

Main Results:

  • Cripto expression was detected in 67% of hyperplasias, 58% of adenomas, and 68% of adenocarcinomas.
  • No significant correlation was found between Cripto expression and tumor invasion, stage, or prognosis.
  • A higher incidence of Cripto expression was observed in well-differentiated and papillary adenocarcinomas compared to poorly differentiated ones (P < 0.05).

Conclusions:

  • Cripto expression in gallbladder lesions is common.
  • Cripto expression may be associated with tumor differentiation rather than tumor progression in gallbladder carcinomas.